-
Type:
Change Request
-
Resolution: Unresolved
-
Priority:
Highest
-
FHIR Core (FHIR)
-
R4B
-
Biomedical Research & Regulation
-
STU
-
ClinicalUseDefinition (was ClinicalUseIssue)
Ingredient
ManufacturedItemDefinition
Medication
MedicinalProductDefinition
PackagedProductDefinition
RegulatedAuthorization
SubstanceDefinition
SubstancePolymer
SubstanceReferenceInformation
The listed resources add significant granularity and specificity for definition, potential adverse events and other metadata to support labeling and, potentially, research and reuse. However, the number of new resources is somewhat overwhelming and requires guidance with an example or three to show how these resources may be used to reference and manage use of a medication. I understand these are all Maturity Level 1 but some general guidance is essential to avoid confusion and potential misuse of these resources.
- is voted on by
-
BALLOT-16036 Negative - Floyd Eisenberg : 2021-May-FHIR R4B STU
- Balloted